Citation: | CAO Bing, JI Tao, ZHOU Bin, JIAO Guoqing, ZOU Jian. Significance of microRNA-155 expression in gastric cancer[J]. Journal of Clinical Medicine in Practice, 2013, (21): 43-45. DOI: 10.7619/jcmp.201321012 |
刘霞, 代荫梅, 张为远. MicroRNA在妇科肿瘤中的研究进展 [J]. {H}中华医学杂志, 2009, (5):357.doi: 10.3760/cma.j.issn.0376-2491.2009.05.019.
|
Xiang X, Zhuang X, Ju S. miR-155promotes macroscopic tumor formation yet inhibits tumor dissemination from mammary fat pads to the lung by preventing EMT [J]. {H}ONCOGENE, 2011.3440.
|
Gironella M, Seux M, Xie M J. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development [J]. Prec Natl Acad Sci USA, 2007.16170.
|
Guo H Q, Huang G L, Guo C C. Diagnostic and prognostic value of circμLating miR-221 for extranodal natural killer/T-cell lymphoma [J]. DisMarkers, 2010(5):251.
|
Huang Z, Huang D, Ni S. Plasma microRNAs are promising novel biomarkers forearly detection of colorectal cancer [J]. {H}International Journal of Cancer, 2010(1):118.
|
Brase J C, Johannes M, Schlomm T. CircμLating miRNAs are correlated with tumor progression in prostate cancer [J]. {H}International Journal of Cancer, 2011(3):608.
|
Li A, Omura N, Hong S M. Pancreatic cancers epigenetically silence SIPI and hypomethylate and over express miR-200a/200b in association with elevated circμLating miR-200a and miR-200b levels [J]. {H}CANCER RESEARCH, 2010, (13):5226.
|